APA (7th ed.) Citation

Hermann, V., Batalov, A., Smakotina, S., Juif, P., & Cornelisse, P. First use of cenerimod, a selective S1P1 receptor modulator, for the treatment of SLE: A double-blind, randomised, placebo-controlled, proof-of-concept study. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Hermann, Viktoria, Anastas Batalov, Svetlana Smakotina, Pierre-Eric Juif, and Peter Cornelisse. First Use of Cenerimod, a Selective S1P1 Receptor Modulator, for the Treatment of SLE: A Double-blind, Randomised, Placebo-controlled, Proof-of-concept Study. BMJ Publishing Group.

MLA (9th ed.) Citation

Hermann, Viktoria, et al. First Use of Cenerimod, a Selective S1P1 Receptor Modulator, for the Treatment of SLE: A Double-blind, Randomised, Placebo-controlled, Proof-of-concept Study. BMJ Publishing Group.